Device
Group using new oropharyngeal airway (experimental group)
Total Trials
2
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph not_applicable
2
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Active(2)
Detailed Status
Not yet recruiting2
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
not_yet_recruiting2100%
Recent Activity
0 active trials
Showing 2 of 2
not_yet_recruitingnot_applicable
Application of New Oropharyngeal Airway Management in Obese Patients Undergoing Painless Gastroenteroscopy
NCT06590922
not_yet_recruitingnot_applicable
Observation of Clinical Effect of New Oropharyngeal Airway in Patients With OSHAS During Painless Gastroenteroscopy
NCT06594380
Clinical Trials (2)
Showing 2 of 2 trials
NCT06590922Not Applicable
Application of New Oropharyngeal Airway Management in Obese Patients Undergoing Painless Gastroenteroscopy
NCT06594380Not Applicable
Observation of Clinical Effect of New Oropharyngeal Airway in Patients With OSHAS During Painless Gastroenteroscopy
All 2 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 2